This study, called the RADIQAL Study, is looking at two different X-ray imaging systems used during heart procedures for people with coronary artery disease (blocked heart arteries). It compares the Azurion system with Xres5 to the standard Azurion system with ClarityIQ (Xres4). Researchers want to see if the new Xres5 system can reduce the amount of radiation you receive and how well the procedure goes. You might be able to join if you are 18 or older, need a diagnostic angiography or coronary intervention, and can give your consent. The study aims to enroll 824 participants. The study's success will be measured by the patient's radiation dose and how well the procedure is performed.

Study design

This is a prospective, randomized study where participants are randomly assigned to one of two groups (1:1 ratio) to receive either the Xres5 or ClarityIQ imaging system. It is an unblinded study, meaning both you and your doctor will know which system is being used.

What's involved

You will be screened, give written consent, and then be randomly assigned to receive treatment with either the Azurion system with Xres5 or the standard of care (ClarityIQ/Xres4). The study procedures end after your coronary procedure is completed.

Compensation

Not stated in the trial record.

Follow-up

There will be no modifications to your standard follow-up care after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.